期刊文献+

耐碳青霉烯鲍曼不动杆菌耐药机制及分子流行病学研究 被引量:9

Molecular epidemiology and multidrug resistance mechanisms of carbapenem-resistance Acinetobacter baumannii
下载PDF
导出
摘要 目的:阐明耐碳青霉烯鲍曼不动杆菌(CRAB)主要耐药机制和分子流行病学特征。方法:PCR方法检测常见碳青霉烯酶基因,PCR-RELP分型及基因测序检测整合子Ⅰ和ISCR1,ERIC-PCR及聚类分析研究克隆相关性。结果:碳青霉烯酶基因NDM、IMP、VIM、OXA-23-like、OXA-24-like、OXA-51-like、OXA-58-like检出率分别为4.1%、22.9%、26.0%、67.7%、63.5%、46.8%、65.6%。整合子Ⅰ可变区分为12个耐药基因盒排列类型,A6和A12首次在鲍曼不动杆菌中发现;ISCR1可变区分为6个类型。将耐药机制、ERIC-PCR及聚类分析结合临床资料综合分析,CRAB感染患者均为散发,粪便中CRAB不是临床感染来源。结论:CRAB主要耐药机制是产碳青霉烯酶及整合子Ⅰ、ISCR1携带率高,ERIC-PCR基因分型结合耐药机制研究适用于分子流行病学调查。 Objective To clarify the molecular epidemiology and multidrug resistance mechanisms of carbapenem-resistance Acinetobacter baumannii(CRAB). Methods Carbapenemase genes were analyzed by PCR. Class I integron and ISCRI were analyzed by PCR- RFLP, and cloning correlation was performed by ERIC- PCR and cluster analysis. Results The carriage rate of carbapenemase gene blaNDM,blalMP, blaVIM,blaOXA- 23-1ike,blaOXA-24-1ike, blaOXA-51-1ike,and blaOXA-58-1ike were 4.1% ,22.9% ,26.0% ,67.7% ,63.5% , 46.8%,and 65.6%,respectively. Twelve different gene cassette arrays were found in variable region of class I integron-positive isolates. A6 and A12 were first described in Acinetobacter baumannii,and 6 different gene cassette arrays were found in variable region of ISCR1 -positive isolates. Resistance mechanisms, ERIC-PCR and cluster analysis combined with clinical information, indicated that patients who were infected by CRAB were sporadic and inpatient stool specimens were not the source of clinical infection. Conclusions Mechanisms of carbapenem resistant Acinetobacter baumannii arc mainly producing carbapenemases and carrying class I integron and ISCR1. ERIC-PCR genotyping technologies combined with resistance mechanisms are applicable for molecular epidemiology studies.
出处 《实用医学杂志》 CAS 北大核心 2015年第24期4129-4132,共4页 The Journal of Practical Medicine
基金 广东省科技计划项目(编号:2013B010404021 2014A010107011)
关键词 耐碳青霉烯鲍曼不动杆菌 碳青霉烯酶 整合子 ISCR ERIC-PCR carbapenem-resistance Acinetobacter baumannii (CRAB) carbapenemases integron ISCR ERIC-PCR
  • 相关文献

参考文献13

  • 1Novovic K, Mihajlovic $, Vasfljevic Z, et al. Carbapenem- resistant Acinetobacter baumannii from serbia: revision of cad) classification [J]. PLo$ One,2015, 10(3): e122793.
  • 2Liu Q, Li W, Du X, et al. Risk and prognostic factors for multidrug-resistam Acinetobacter baumannii complex bactoremia: A Retrospective Study in a Tertiary Hospital of West China [J]. PLoS One, 2015, 10(6): e130701.
  • 3Wu K, Wang F, Sun J, et 81. Class 1 integron gene cassettes in multidrug-resistant Gram-negative bacteria in southern China [J]. Int J Antimicrob Ag, 2012, 40(3): 264-267.
  • 4Wang F, Wu K, Sun J, et 8.1. Novel ISCRl-tinked resistance genes found in multidrug-resistant Gram-negative bacteria in southern China [J]. Int J Antimicrob Ag,2012, 40(5): 404- 408.
  • 5Ye D, Shan J, Huang Y, et al. A gloves-associated outbreak of imipenem-resistant Acinetobacter baumannii in an intensive care unit in Guangdong, China [J]. BMC Infect Dis, 2015, 15(1):179.
  • 6Chen TL, Siu LK, Wu RC, et al. Comparison of one-tube multiplex PCR, automated ribotyping and intergenic spacer (ITS) sequencing for rapid identification of Acinetobacter baumannii [J]. Clin Mierobiol Infect, 2007, 13(8) : 801-806.
  • 7Poirel L, Walsh TR, Cuvillier V, et al. Multiplex PCR for detection of acquired carbapenemase genes [J]. Diagn Microbiol Inlct Dis, 2011, 70(1): 119-123.
  • 8Woodford N, Ellington MJ, Coelho JM, et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp [J]. Int J Antimicrob Agents, 2006, 27 (4) : 351-353.
  • 9Wei Q, Hu Q, Li S, et al. A novel functional class 2 integron in clinical Proteus mirabilis isolates [J]. J Antimierob Chemother,2014, 69(4): 973-976.
  • 10Grundmann H, Livennore DM, Giske CG, et al. Carbapenem- non-susceptible Enterobaeteriaceae in Europe: conclusions from a meeting of national experts [J]. Euro Surveill, 2010, 15 (46) : 23-34.

二级参考文献34

  • 1中华人民共和国卫生部.医疗机构消毒技术规范[s].2012.
  • 2Karageorgopoulos DE, Falagas ME. Current control and treatment of muhidnJg-resistant Acinetobacter baunuznnii infections. Lancet Intact Dis, 2008, 8:751-762.
  • 3Peleg AY, Seiferl H, Paterson DL. Acinetobacter baumannii: emerg, ence of a successful pathogen. Clin Microbiol Rev, 2008, 21:538-582.
  • 4Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosonnal DNA restriction patterns produced by pulsed-field gel electrnphnresis: criteria for bacterial strain typing. J Clin Microbiol, 1995, 33:2233-2239.
  • 5Maiden MC. Muhilocus sequence typing of bacteria. Annu Rev Microbiol, 2006, 60:561-588.
  • 6Mugnier PD, Poirel L, Naas T, et al. Worldwide dissemination of the blaoxa-23 carbapenemase gene of Acinetobacter bauntannii. Emerg Infect Dis, 2010, 16:35-40.
  • 7Diancourt L, Passet V, Nemec A, et al. The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One, 2010, 5:e10034.
  • 8Turton JF, Woodford N, Glover J, et al. Identification of Acinetobacter baumannii by detection of the blaOXA-51-1ike carbapenemase gene intrinsic to this species. J Clin Microbiol, 2006, 44:2974-2976.
  • 9Bartual SG, Seifert H, Hippler C, et al. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J Clin Microbiol, 2005, 43 : 4382-4390.
  • 10Fu Y, Zhou J, Zhou H, et al. Wide dissemination of OXA-23- producing carbapenem-resistant Acinetobacter baumannii clonal complex 22 in multiple cities of China. J Antimicrob Chemother, 2010, 65:644-650.

共引文献28

同被引文献96

引证文献9

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部